CDW Options Traders Turn Bullish After Stock's Worst Week in Months

CDW Corporation heads into the post-earnings week with an unusual split: the stock just fell 7.2% in five days, yet options positioning is the most bullish it has been all year.

The options market is the loudest signal right now. The put/call ratio dropped to 0.84, almost three standard deviations below its 20-day average of 1.03. That is the lowest PCR reading of the past 52 weeks, which bottomed at 0.07 in an outlier session but has spent most of the year well above 1.0. For a stock that has consistently attracted more put buying than call buying, the sudden shift toward calls is striking. It happened precisely as the stock fell from above $160 to $149.77, suggesting buyers are using the dip to position for a recovery rather than adding to defensive hedges.

Short interest, by contrast, tells a quieter story. At 6.9% of free float, the short position is not trivial, but it has been easing. Shorts fell nearly 3% over the week and are essentially flat over the past month at around 9 million shares. Borrowing remains cheap at 0.44%, up roughly 4% on the week but still firmly in ordinary territory. Availability is extremely loose at 736%, meaning the lending pool is barely touched relative to what has actually been borrowed. There is no squeeze pressure here, and the short score of 50.2 sits at the mid-point of the ORTEX universe, drifting lower from 52.3 two weeks ago. Shorts are not pressing.

The Street is modestly constructive but not excited. Morgan Stanley carries an Overweight with a $171 target, the most bullish published view in recent months, following an upgrade in June. Barclays trimmed its target to $148 in September, fractionally below the current price, holding an Equal-Weight. Citigroup and JPMorgan both sit at neutral-equivalent ratings. The mean price target of around $159 implies roughly 6% upside from $149.77, a gap that explains why the stock has not attracted stronger conviction buying: the implied return is too slim to move funds. On valuation, the PE is running at 12.6 times and EV/EBITDA at 10.4 times, with EV/EBITDA down modestly over the past week as the price slipped. The forward earnings growth score ranks in the 92nd percentile, a standout, while near-term EPS momentum scores (36th and 38th percentile over 30 and 90 days) are more subdued. The earnings yield ranks in the 82nd percentile, which supports the value case at current prices.

One institutional note worth flagging: BlackRock Portfolio Management filed a fresh Schedule 13G on October 27, disclosing a 5.9% stake. The parent entity, BlackRock Inc., separately reports 12.2% of shares as of end-September, adding 846,000 shares in the quarter. The combined picture is of the largest holder continuing to build. Pzena Investment Management added 1.5 million shares in Q3, taking its stake to 2.1% of the company. These are passive and value-oriented buyers, not activists, and no 13D filings are on the register. As always with 13D/G disclosures, stakes are reported around the 5% threshold and positions can change without further filing.

Retail attention has also picked up. Wikipedia page views for CDW are running at a z-score of 2.4 against the company's own 90-day history, the highest attention reading in the dataset's recent window. This is a measure of retail awareness, not a revenue indicator, but the spike roughly coincides with the earnings release on November 4 and the week's price drop.

The next scheduled earnings report is not until February 3, 2027, so the near-term question is whether the options-market bullishness around the dip holds as the post-earnings dust settles and whether the Street finds reason to close the gap between current targets and current prices.